Michele Reni (M Reni)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Venues

Cancer chemotherapy and pharmacology

British journal of cancer

BMC cancer

Annals of surgical oncology

Ospedale San Raffaele

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Ospedale San Raffaele Jan 01 2016

Italy

Direttore programma strategico coordinamento clinico Pancreas Center :: Medical Oncology

Publications

Gilles Manceau, Thomas Seufferlein, Michele Reni, Daniel H Palmer, John A Bridgewater, Antonio Cubillo, Gerald W Prager, Alice Vermeire, Fabienne Hédouin-Biville, Zhaoyang Teng, Teresa Macarulla
Treatment sequences and prognostic/predictive factors in metastatic pancreatic ductal adenocarcinoma: univariate and multivariate analyses of a real-world study in Europe. BMC cancer 23 (1) (2023)
Anna Maria Militello, Giulia Orsi, Alessandro Cavaliere, Monica Niger, Antonio Avallone, Lisa Salvatore, Giampaolo Tortora, Ilario Giovanni Rapposelli, Guido Giordano, Silvia Noventa, Elisa Giommoni, Silvia Bozzarelli, Marina Macchini, Umberto Peretti, Letizia Procaccio, Alberto Puccini, Stefano Cascinu, Cristina Montagna, Michele Milella, Michele Reni
Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes. Cancer chemotherapy and pharmacology (2023)
Giulia Orsi, Alessandro Cavaliere, Giampaolo Tortora, Sara Lonardi, Marina Macchini, Mariacristina Di Marco, Guido Giordano, Enrico Vasile, Mario Scartozzi, Silvia Bozzarelli, Silvia Noventa, Maria Grazia Rodriquenz, Anna Maria Militello, Ilario Giovanni Rapposelli, Ingrid Garajovà, Stefania De Lorenzo, Barbara Merelli, Alessandro Bittoni, Lisa Salvatore, Letizia Procaccio, Chiara Paratore, Andrea Spallanzani, Umberto Peretti, Monica Niger, Elisa Giommoni, Ilaria Bernardini, Emiliano Tamburini, Katia Bernardino, Laura Forti, Maria Maddalena Valente, Stefano Cascinu, Michele Milella, Michele Reni
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv). British journal of cancer (2022)
M Redegalli, M Schiavo Lena, M G Cangi, C E Smart, M Mori, C Fiorino, P G Arcidiacono, G Balzano, M Falconi, Michele Reni, C Doglioni
Proposal for a New Pathologic Prognostic Index After Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma (PINC). Annals of surgical oncology 29 (6) (2022)
Marina Macchini, Umberto Peretti, Giulia Orsi, Silvia Zanon, Elena Mazza, Maria Maddalena Valente, Domenico Tamburrino, Giulio Belfiori, Gemma Rossi, Sabrina Gloria Giulia Testoni, Paolo Passoni, Claudio Doglioni, Stefano Cascinu, Michele Reni
Exploring chemotherapy holiday and drugs re-challenge in advanced pancreatic cancer patients. Cancer chemotherapy and pharmacology 87 (1) (2020)
Michele Reni, Umberto Peretti, Silvia Zanon, Marina Macchini, Gianpaolo Balzano, Elena Mazza, Domenico Tamburrino, Giulia Orsi, Paolo Giorgio Arcidiacono, Massimo Falconi, Luca Gianni
Time to CA19-9 nadir: a clue for defining optimal treatment duration in patients with resectable pancreatic ductal adenocarcinoma. Cancer chemotherapy and pharmacology 85 (4) (2020)

Michele Reni.css-eqlu8i{font-size:small;padding-left:4px;} (M Reni)

Publication Activity (10 Years)

Top Topics

Top Venues

Michele Reni (M Reni)